Publications by authors named "Peter Maycox"

21 Publications

  • Page 1 of 1

Abnormalities in α/β-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA1 receptor knockout mice.

Int J Neuropsychopharmacol 2011 Aug 14;14(7):941-53. Epub 2010 Oct 14.

Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases, University of Milano, Italy.

View Article and Find Full Text PDF
August 2011

Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.

Biochem Soc Trans 2009 Oct;37(Pt 5):1139-43

Synaptic Plasticity and Neural Network Dynamics DPU, Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex, UK.

View Article and Find Full Text PDF
October 2009

Investigation of G72 (DAOA) expression in the human brain.

BMC Psychiatry 2008 Dec 11;8:94. Epub 2008 Dec 11.

Psychiatry, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, CM19 5AW, UK.

View Article and Find Full Text PDF
December 2008

Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.

Prog Neuropsychopharmacol Biol Psychiatry 2008 Feb 16;32(2):414-22. Epub 2007 Sep 16.

Biology Department, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline plc, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK.

View Article and Find Full Text PDF
February 2008

Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia.

Behav Brain Funct 2007 Jun 28;3:31. Epub 2007 Jun 28.

Psychiatry CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW Harlow, Essex, UK.

View Article and Find Full Text PDF
June 2007

The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.

Mol Cell Neurosci 2006 May-Jun;32(1-2):27-36. Epub 2006 Mar 13.

Schizophrenia and Bipolar Neurophysiology and Pharmacology Research Department, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, Third Avenue, Harlow, Essex, CM19 5AW, UK.

View Article and Find Full Text PDF
September 2006

Neurochemical changes in LPA1 receptor deficient mice--a putative model of schizophrenia.

Neurochem Res 2005 Mar;30(3):371-7

Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, CM19 5AW, Harlow, Essex, UK.

View Article and Find Full Text PDF
March 2005

Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.

Bipolar Disord 2005 Feb;7(1):33-41

Schizophrenia and Bipolar Disorder Research Department, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, Harlow, Essex, UK.

View Article and Find Full Text PDF
February 2005

Mutation of charged residues in the TR3 death domain does not perturb interaction with TRADD.

Protein Eng 2002 Oct;15(10):811-5

Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Third Avenue, Harlow, EssexCM19 5AW, UK.

View Article and Find Full Text PDF
October 2002